Azurity Pharma gets USFDA approval for Fleqsuvy
Nearly 1 million people are living with multiple sclerosis in the United States. Spasticity is a commonly reported symptom for MS, with an estimated prevalence of spasticity of 67%
Nearly 1 million people are living with multiple sclerosis in the United States. Spasticity is a commonly reported symptom for MS, with an estimated prevalence of spasticity of 67%
The six-layer packaging ensures that external media such as bacteria, light and air do not contaminate the liquid
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
The stability is led by healthy demand in the domestic and emerging markets
The study will be published on the pre-print server, medRXiv, shortly
Six months after receipt of the second Covaxin dose, participants received booster dose of the same. The trial demonstrated long-term safety with no serious events
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
The revolutionary new nano coating is easy to apply and rejects liquid-based contagions like COVID-19/SARS-CoV-2 and variants, influenzas, and rhinoviruses and is available via ready-to-use sprays or pre-treated air filters
While continuing to offer its current breadth of genomic services, Biogazelle will become CellCarta's Center of Excellence for the development of complex genomic biomarker assays
Subscribe To Our Newsletter & Stay Updated